Resolax 1 MG (Prucalopride)

Basic Product Information of Resolax (Prucalopride) 1mg

How Resolax (Prucalopride) Works

Resolax contains Prucalopride, a highly selective agonist of the serotonin type-4 (5-HT4) receptor. Prucalopride shows negligible activity at other serotonin receptor subtypes, including 5-HT2A, 5-HT2B, and 5-HT3, at concentrations well above its 5-HT4 receptor affinity, giving it a more targeted mechanism than older, less selective GI prokinetic agents.

By activating 5-HT4 receptors in the gut wall, Prucalopride stimulates high-amplitude propagating contractions in the colon, the coordinated muscular contractions responsible for moving stool through the large intestine. This increases overall bowel motility and the frequency of complete spontaneous bowel movements in patients with chronic constipation that has not responded adequately to standard laxative therapy.

Resolax is taken as a once-daily oral tablet, with or without food, at any time of day. Because the mode of action relies on stimulating propulsive motility rather than a dose-dependent laxative effect, exceeding the standard 2mg daily dose is not expected to provide additional benefit.

Indication for Resolax (Prucalopride)

Resolax (Prucalopride) is indicated for the following condition:

Benefits of Resolax (Prucalopride) 1mg

How to Take Resolax (Prucalopride)

Monitoring and Dosage Adjustments

Regular monitoring is recommended throughout Resolax treatment. Your physician will monitor for changes in mood or behaviour, particularly persistent worsening of depression or the emergence of suicidal thoughts, and will assess renal function periodically, especially in older patients or those with pre-existing kidney disease. Monitoring also includes assessment of bowel symptoms and response to treatment, since the dose or continued use may be reconsidered if symptoms do not improve. Report any unusual changes in mood, thoughts of self-harm, severe abdominal pain, or signs of bowel obstruction to your doctor immediately.

Drug Interactions and Important Information

Prucalopride is primarily eliminated by the kidneys, with 60 to 65% excreted unchanged in the urine, giving it a comparatively low potential for metabolic drug-drug interactions compared with medications that rely heavily on liver enzyme pathways. Even so, always inform your physician of all medications, supplements, and herbal products you are currently taking before starting Resolax, particularly any medicines that affect mood or mental health.

Inform your physician of any personal or family history of depression, self-harm, or suicidal thoughts before starting treatment, as well as any history of inflammatory bowel disease or bowel obstruction. Discontinue Resolax and contact your physician immediately if you experience any unusual changes in mood, thoughts of self-harm, or worsening depression while taking this medicine.

Side Effects and Precautions

Who Should Use Resolax (Prucalopride)?

Resolax is suitable for adults with chronic idiopathic constipation that has not responded adequately to standard laxative therapy, including older adults, and patients with severe hepatic or renal impairment where a reduced starting dose is appropriate. It is prescribed by gastroenterologists, internists, and general practitioners managing chronic constipation. A thorough medical assessment to rule out bowel obstruction or inflammatory bowel disease, and a review of mental health history, is recommended before initiating treatment.

Manufacturer: Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in Dhaka, Bangladesh, with a broad portfolio spanning oncology, nephrology, virology, and gastrointestinal medicines. Operating under Bangladesh’s TRIPS/Doha Declaration exemption for least-developed countries, Everest manufactures advanced generics such as Resolax under cGMP-compliant standards, with the stated mission of making high-quality medicines accessible and affordable to patients around the world. Resolax offers a bioequivalent alternative to Motegrity and Resolor at a fraction of the cost.

Global Supplier: Mediaid Pharmacy with Worldwide Shipping

Mediaid Pharmacy is a trusted global supplier of specialty medications. We ensure Resolax (Prucalopride) is accessible to patients and healthcare providers worldwide through reliable worldwide shipping. Whether you are located in South Asia, the Middle East, Africa, Europe, or beyond, Mediaid Pharmacy provides fast and reliable delivery with full order support. Contact us directly via WhatsApp, phone, or WeChat for pricing, availability, and delivery enquiries.

Why Choose Resolax (Prucalopride) from Mediaid Pharmacy?

Resolax represents a targeted, well-studied option for patients whose chronic constipation has not responded to standard laxatives. As the generic equivalent of Motegrity and Resolor, it delivers the same active ingredient, Prucalopride, with the same proven 5-HT4 receptor agonist mechanism at a dramatically more affordable price. Manufactured by Everest Pharmaceuticals Ltd. under cGMP-compliant standards and distributed globally by Mediaid Pharmacy, Resolax gives patients worldwide access to effective, evidence-based constipation therapy without the financial burden of brand-name alternatives. For patients and physicians seeking a proven, affordable, and accessible Prucalopride option with worldwide delivery, Resolax from Mediaid Pharmacy is the trusted choice.

Frequently Asked Questions About Resolax (Prucalopride)